Sign in

CIK 0001971387 · <br>Emerging growth company

Liminatus Pharma, Inc.

Sign in to watch
Ticker
LIMN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
213-273-5453
Business address
12611 HIDDENCREEK WAY, UNIT C, CERRITOS, CA, 90703
Former names
Iris Parent Holding Corp.

Securities

  • LIMN Class A Common Stock Nasdaq
  • LIMNW Warrants Nasdaq
  1. EFFECT Other Notice of Effectiveness
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. POS AM Other Post-effective Amendment for Registration Statement
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. UPLOAD Other SEC-generated Letter
  6. POS AM Other Post-effective Amendment for Registration Statement
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. POS AM Other Post-effective Amendment for Registration Statement
  10. 424B3 Offering Prospectus
  11. EFFECT Other Notice of Effectiveness
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. S-4/A Deal Registration Statement - Business Combination
  14. S-4/A Deal Registration Statement - Business Combination
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. UPLOAD Other SEC-generated Letter
  17. S-4/A Deal Registration Statement - Business Combination
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. UPLOAD Other SEC-generated Letter
  20. S-4/A Deal Registration Statement - Business Combination

Page 5 of 6 · 109 filings